The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever
Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions
Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
Linda Elsegood: Welcome to the LDN radio show brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.
LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Questions Answered Live by
Pharmacist Dr Masoud Rashidi - LDN Specialist
Dr Sato-Re
Dr Mathewson
Sponsored by Innovative Compounding Pharmacy icpfolsom.com
Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn's disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
BMJ Open
08 April 2022
https://pubmed.ncbi.nlm.nih.gov/35396307/